Gutted Cambridge biotech declares bankruptcy after failed merger, layoffs


It's (almost) the end for Infinity Pharmaceuticals. Following a failed merger agreement and layoffs that left the company with just three employees, the Cambridge biotech has declared bankruptcy.

Previous Beth Israel Lahey Health appoints new president of behavioral services
Next JBG Smith opens rebooted Crystal City Water Park with 9 new eateries